Obsessive-compulsive disorder is characterized by the presence of either obsessions or compulsions, but more commonly by both symptoms that can cause marked impairment or distress.
Obsession is a recurrent, persistent, intrusive, unwanted thought, image or urge that cause distressing emotions (eg anxiety and disgust).
Compulsion is a repetitive behavior or mental act that the person feels driven to perform, in order to lessen the distress caused by the obsession.
Anxiety is the central feature of obsessive-compulsive disorder.
Mental disorders and chronic physical conditions represent a serious public health burden in Singapore, with chronic pain, major depressive disorder, obsessive compulsive disorder, cardiovascular disease and generalized anxiety disorder being the top five contributors to increased number of years lived with disability in the general population, according to a recent study.
Deep brain stimulation (DBS) of the ventral anterior limb of the internal capsule (vALIC) is well tolerated and effective for patients with treatment-refractory obsessive-compulsive disorder (OCD), a recent study has shown.
More than three-fourths of people with mood, anxiety and alcohol use disorder in Singapore receive no treatment for their condition, reflecting a high treatment gap in mental healthcare that has remained a matter of concern for years now, according to data from the 2016 Singapore Mental Health Study.
Individuals with obsessive–compulsive disorder (OCD) with a chronic illness course are at greater risk of remaining chronic, which, in turn, is associated with poor clinical outcome, according to a study.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Psychiatry - Malaysia digital copy today!
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa,
08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.